Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres
Dean Fennell, Daniel Griffiths, Zina Eminton, Abigail Morgan-Fox, Kayleigh Hill, Sean Ewings, Charlotte Stuart, Lucy Johnson, Kim Mallard, Mavis Nye, Liz Darlison, Sean Dulloo, Judith Cave, Jin-Li Luo, Paul Taylor, Jake Spicer, Charlotte Poile, Aleksandra Bzura, Gareth Griffiths
BMJ Open Nov 2023, 13 (11) e073120; DOI: 10.1136/bmjopen-2023-073120